Neuraptive Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 4

Neuraptive Therapeutics General Information

Description

Developer of a therapeutic technology intended to improve the speed and quality of recovery from peripheral nerve injury. The company is developing a suite of advanced microsurgical instruments for use in peripheral nerve surgery after trauma or during face and body reconstructive procedures, enabling patients to rapidly recover their damaged peripheral nerve injuries and also reduce their pain.

Contact Information

Website
neuraptive.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Drug Discovery
Biotechnology
Primary Office
  • 2 Logan Square
  • Suite 1930
  • Philadelphia, PA 19103
  • United States
+1 (484) 000-0000

Neuraptive Therapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuraptive Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC $3M Upcoming Clinical Trials - General
4. Later Stage VC 01-Jan-2021 000.00 Completed Clinical Trials - General
3. Early Stage VC (Series A) 19-Dec-2018 000.00 000.00 000.00 Completed Clinical Trials - General
2. Angel (individual) 15-Aug-2018 $100K $1.1M Completed Startup
1. Angel (individual) 06-Sep-2017 $1M $1M Completed Startup
To view Neuraptive Therapeutics’s complete valuation and funding history, request access »

Neuraptive Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view Neuraptive Therapeutics’s complete cap table history, request access »

Neuraptive Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a therapeutic technology intended to improve the speed and quality of recovery from peripheral nerve injury
Therapeutic Devices
Philadelphia, PA
13 As of 2021
000.00
00000 00000

000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
00000000 0000000
Alachua, FL
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuraptive Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Formerly VC-backed Alachua, FL 000 000.00 00000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Neuraptive Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Stefan Proniuk Ph.D Chief Development Officer
David Jackson Ph.D Co-Founder & Board Member
Robert Radie Chief Executive Officer & Chairman
Evan Tzanis Chief Operating Officer, Executive Vice President and Head of Research and Development
You’re viewing 4 of 7 executive team members. Get the full list »

Neuraptive Therapeutics Board Members (7)

Name Representing Role Since
David Jackson Ph.D Neuraptive Therapeutics Co-Founder & Board Member 000 0000
David Pierce Self Board Member 000 0000
Ivan Gergel MD New Rhein Healthcare Board Member 000 0000
Nayan Parekh Ph.D New Rhein Healthcare Board Member 000 0000
Randolph Hubbell Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Neuraptive Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuraptive Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
Central Texas Angel Network Angel Group Minority 000 0000 000000 0
New Rhein Healthcare Growth/Expansion Minority 000 0000 000000 0
To view Neuraptive Therapeutics’s complete investors history, request access »